Improved prognosis assessment for patients with bladder carcinoma

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 1919-1923

  Otto, Thomas ^a   Bex, Axel ^a   Schmidt, Ulrich ^a   Raz, Avraham ^b,c   Rübben, Herbert ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE MOTILITY FACTOR; GLYCOPROTEIN; GLYCOPROTEIN GP 78; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CADHERINS; DISEASE-FREE SURVIVAL; HUMANS; PROGNOSIS; RECEPTORS, CYTOKINE; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0030909233     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. . Ro JY, Staerkel GA, Ayala AG: Cytologic and histologic features of superficial bladder cancer, Urol Clin North Am 1992, 19:435-453
2. Heney NM: Natural history of superficial bladder cancer. Urol Clin North Am 1992, 19:429-433
3. Badalament RA, Ortolano V, Burgers JK: Recurrent or aggressive bladder cancer: indications for adjuvant intravesical therapy. Urol Clin North Am 1992, 19:485-498
4. Raghavan D, Shipley W, Garnick MB, Russell PJ, Richie JP: Biology and management of bladder cancer, N Engl J Med 1990, 322:1129-1138
5. RUTT (Registry for Urinary Tract Tumors): Harnwegs-tumorregister. Jahresbericht Verh Dtsch Ges Urol 1985, 37:366
6. Bringuier PP: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993, 53:3241-3245
7. Otto T: Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res 1994, 54:3120-3123
8. Syrigos KM: E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumor stage, and survival. Int J Cancer 1995, 64:367-370
9. Silletti S: Autocrine motility factor receptor in human bladder carcinoma: gene expression, loss of cell-contact regulation, and chromosomal mapping. Int J Oncol 1993, 3:801-807
10. Hermanek P: Neue TNM/pTNM-Klassifikation und Stadieneintelung urologischer: Tumoren ab, 1987. Urologe(B) 1986, 26:193-197
11. Frixen UH: E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991, 113:173-185
12. Peto R, Peto J: Asymptotically efficient rank invariation test procedures. Jr Stat Soc A 1972, 135
13. Peto R, Pike MC: Design and analysis of clinical trials requiring prolonged observation of each patient, Br J Cancer 1976, 34:585-612;
14. 1977, 35:1-39
15. Birchmeier W, Hulsken J, Behrens J: E-cadherin as an invasion suppressor. Ciba Found Symp 1995, 189:124-136
16. Silletti S, Raz A: Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis. Attempts to Understand Metastasis Formation (Current Topics in Microbiology and Immunology), Edited by U Gunthert, PM Schlag, W Birchmeier, Berlin, Springer-Verlag, 1996, pp 138-169
17. Liotta LA: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 1986, 83:3302-3306
18. Huang B, Xie Y, Raz A: Identification of an upstream region that controls the transcription of the human autocrine motility factor receptor. Bioch Biophys Res Commun 1995, 212:727-742